Biomarkers for Parkinson’s disease and Alzheimer’s disease
<p>Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) represent the two most prevalent neurodegenerative diseases in the world, affecting 30 million and 5 million people, respectively. As populations age, the global burden of AD and PD will increase, resulting in significant societal and ec...
| Hoofdauteur: | |
|---|---|
| Andere auteurs: | |
| Formaat: | Thesis |
| Gepubliceerd in: |
2018
|